MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM

基于少数民族的社区肿瘤学计划

• 批准号: 10224106
• 负责人: Benjamin Adam Gartrell
• 金额: $ 84.02万
• 依托单位: MONTEFIORE MEDICAL CENTER (BRONX, NY)
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10224106
• 关键词: Academic Medical Centers; Address; Adjuvant; Adjuvant Study; Advanced Malignant Neoplasm; Aftercare; Albert Einstein Cancer Center; American College of Radiology Imaging Network; Anal carcinoma; Area; Biological Markers; Black race; Breast Cancer Detection; Cancer Center; Cancer Control; Cancer Patient; Caring; Clinical; Clinical Research; Collection; Committee Members; Communities; Community Clinical Oncology Program; County; Coupled; Diagnosis; Doctor of Philosophy; Eastern Cooperative Oncology Group; Ethnic Origin; Evaluation; Faculty; Foundations; Funding; Goals; Health system; Hematopoietic Neoplasms; Hispanics; Home; Infrastructure; Institution; Language; Leadership; Malignant Neoplasms; Measurement; Medical center; Medicine; Mentors; Methodology; Methods; Minority; Minority Groups; Minority Participation; Mission; Morbidity - disease rate; NCI-Designated Cancer Center; Neuropathy; New York; Nivolumab; Outcome; Outcomes Research; Patient Care; Patients; Pilot Projects; Prevention; Protocols documentation; Recording of previous events; Research; Research Personnel; Resources; Role; SECTM1 gene; Science; Screening for cancer; Site; System; Therapeutic; Therapeutic Trials; Training; Training Programs; Training Support; Training and Education; Translational Research; Underrepresented Minority; United States; Urban Community; anticancer research; base; biomarker validation; black women; cancer care; cancer clinical trial; cancer health disparity; cancer imaging; cancer prevention; cancer therapy; care delivery; career; college; experience; federal poverty level; financial toxicity; health care delivery; health related quality of life; innovation; institutional capacity; malignant breast neoplasm; member; minority subjects; mortality; novel; oncology program; patient engagement; population based; postgraduate education; precision medicine; programs; prospective; screening; success; taxane; treatment trial; trial design; underserved community; underserved minority

The overall goals of the Montefiore-Einstein minority-based NCORP community site are to advance the diagnosis, prevention, and management of early and advanced cancer by participating in NCORP trials as a minority/underserved community site, and contributing scientifically and administratively to the NCORP research bases. This will be accomplished by leveraging the strengths of the Montefiore Health System (MHS), including Montefiore Medical Center (MMC), which brings strengths in integrated patient care and innovative health care delivery systems in an academic medical center serving a largely minority population, and the Albert Einstein College of Medicine and Cancer Center (Einstein), which brings strength in training and education, and in baslc, translational, and clinical research through its NCI- designated cancer center. The MMC-Einstein program also brings critical leadership to the NCORP Research Bases, including ECOG-ACRIN, Alliance, and NRG, including leadership roles at the level of the group chair's office, scientific committee chair (or co-chair), and protocol chair (or co-chair). Our plans build upon our long-standing involvement in all aspects of cancer research as a main member of ECOG for 45 years and an NCI-designated cancer center for 48 years, and a strong history of minority accrual to cancer treatment trials (about 65%of all patients). MMC serves the Bronx, an urban community of 1.47 million residents, of whom 89% are minorities and 29% live below the federal poverty level. In the prior funding period we had a strong track record scientific contributions to the NCORP research bases, and met our accrual targets with exceptionally strong minority participation. In the next funding period, we will continue our strong leadership in cancer therapeutics (EA2165), expand the spectrum of our activities to include new programs in cancer imaging and screening (TMIST), cancer control/prevention (EAZ171), and cancer care delivery research (CCDR). The MMC-Einstein NCORP program is led by faculty with experience in cancer therapeutics and biomarker research (J. Sparano, MD), precision medicine and immunoncology (B. Halmos, MD), and CCDR and cancer prevention/control (B. Rapkin, PhD), and is supported by a cadre of other investigators with a broad range of expertise, some of whom benefited from NCI- funded K12 training program in clinical cancer research.

Montefiore-Einstein少数族裔NCORP社区网站的总体目标是推进